VEGFA and neoplasm: In both bilobar multiple and large HCC cases, if lenvatinib is administered in advance to normalize the tumor blood vessels, suppress the increase in VEGF expression after TACE, and reduce the residual tumor volume prior to the performance of selective TACE, a very good therapeutic effect can be obtained, and the liver function can be preserved.